推进瘤治疗:基于蛋白质的纳米粒子的开发和利用
Shirin Khakpour1, Nushin Hosano2, Zahra Moosavi-Nejad3
1Graduate School of Science and Technology, Kumamoto University, Kumamoto 860-8555, Japan.
Pharmaceutics
|July 27, 2024
概括
基于蛋白质的纳米粒子 (PNPs) 提供有前途的瘤治疗,具有有针对性的输送和低毒性. 本综述将PNP生产方法分为溶解度变化,溶剂替代和薄流技术,以提高理解和应用.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 材料科学 材料科学 材料科学
背景情况:
- 基于蛋白质的纳米粒子 (PNPs) 对于晚期癌症治疗至关重要,因为它们的向传递,低毒性和可调性特征.
- 有效的生产方法对于在各种生物医学应用中利用PNP至关重要,例如药物输送,成像和组织工程.
研究的目的:
- 审查和分类生产基于蛋白质的纳米粒子 (PNPs) 和它们的药物复合物的现有和新方法.
- 为了解PNP生产机制和影响因素提供一个明确的框架.
主要方法:
- 将PNP生产技术分为三个类别:溶解度变化,溶剂替代和薄流方法.
- 分析每个方法的基本原则,影响因素 (大小,形态,稳定性,功能) 和挑战 (可扩展性,可重复性,生物相容性).
主要成果:
- 与其他系统相比,拟议的分类为PNP生产提供了简化和有利的理解.
- 详细讨论与溶解度变化,溶剂替代和薄流方法相关的优点和局限性.
结论:
- 了解PNP生产方法是推动其在瘤治疗和其他生物医学领域应用的关键.
- 新兴趋势和创新策略有望克服当前的局限性,推动PNP技术的未来发展.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498


